Overview
Peggy Hsu is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Her top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
Her clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception E, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).
Rogel Cancer Center
Scott Schuetze is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.
Frequently Asked Questions about Dr. Peggy P. Hsu
How do I make an appointment with Dr. Peggy P. Hsu?
You can book an appointment with Dr. Peggy P. Hsu by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Peggy P. Hsu a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peggy P. Hsu is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Peggy P. Hsu specialize in?
While Dr. Peggy P. Hsu is a Oncology, they have specific expertise in Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Peggy P. Hsu participate in research or clinical trials?
Yes. Dr. Peggy P. Hsu has published 17 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Peggy P. Hsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Peggy P. Hsu accept my insurance?
Dr. Peggy P. Hsu accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Hsu isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Hsu isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Hsu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hsu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)